• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

2.390 -0.040 (-1.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,634
Open 2.410
Bid (Size) 2.350 (9)
Ask (Size) 2.480 (4)
Prev. Close 2.430
Today's Range 2.310 - 2.410
52wk Range 1.720 - 15.70
Shares Outstanding 9,377,034
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Get insights into the top gainers and losers of Monday's after-hours session.
July 14, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data
July 04, 2025
Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours. 
Via Benzinga

Performance

YTD
-50.2%
-50.2%
1 Month
-17.9%
-17.9%
3 Month
-20.9%
-20.9%
6 Month
-22.1%
-22.1%
1 Year
-29.6%
-29.6%

More News

Read More
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
June 27, 2025
Via Newsfile
Topics Regulatory Compliance
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 25, 2025
Via Newsfile
Topics Regulatory Compliance
Here are the top movers in Tuesday's session.
June 24, 2025
Via Chartmill
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
June 24, 2025
Via Investor Brand Network
Curious about the most active stocks on Tuesday?
June 24, 2025
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
June 24, 2025
Via Chartmill
Which stocks are gapping on Tuesday?
June 24, 2025
Via Chartmill
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge
June 24, 2025
Via Benzinga
Tuesday's pre-market session: top gainers and losers
June 24, 2025
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 24, 2025
Via Benzinga
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
June 24, 2025
Via Newsfile
Which stocks are experiencing notable movement on Monday?
June 02, 2025
Via Chartmill
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings
June 02, 2025
Via Benzinga
Topics Stocks
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
June 02, 2025
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
January 22, 2025
Via Benzinga
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
January 21, 2025
Via Stocktwits
Crude Oil Down 2%; D.R. Horton Earnings Top Views
January 21, 2025
Via Benzinga
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
January 21, 2025
Via Benzinga
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results
January 21, 2025
Via Benzinga
Topics Stocks
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
September 30, 2024
Via Investor Brand Network
Topics Intellectual Property
CBDNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth
August 30, 2024
Via Investor Brand Network
Topics Cannabis
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
August 29, 2024
Via Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901
August 26, 2024
Via Investor Brand Network

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
The current price of InMed Pharmaceuticals Inc. - Common Shares is 2.390
When was InMed Pharmaceuticals Inc. - Common Shares last traded?
The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 08/01/25 04:00 PM ET
What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?
The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 22.41M
How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?
InMed Pharmaceuticals Inc. - Common Shares has 22M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap